PRESTIGE PR
Last Updated: 13 Apr 2026
Prestige Biopharma (PBP) is an innovative biopharmaceutical company specializing in the discovery and development of innovative biologics and biosimilars. PBP1510 (Ulenistamab) is the First-in-Class Pancreatic Cancer drug which is on the stage of 1/2a global clinical phase. Based on our innovative biomarker, PAUF, we are continuing the challenge for overcoming hard-to-treat diseases such as pancreatic cancer.
We are developing biosimilars to contribute on the patient's drug accessibility. Over 18 biosimilars we have been developing since 2015.
And also, we are expanding the application of PAUF biomarker to the diagnostics. To expand the effectiveness of pancreatic cancer treatment, we are developing the diagnostic device.
The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis. In parallel with our efforts to enhance safety, efficacy, and affordability of existing antibody therapeutics, PBP thrives to search for new targets and candidates with a goal to free mankind from devastating diseases
Established on core values cherishing life and fostering the spirit of philanthropy, Prestige BioPharma promises to grow everyday to make our dream come true.
Country of registration | Singapore |
Registration number | 53447202L |
Local SIC | |
Incorporation date | 1 Mar 2022 |
Company age | 4 years 3 months |
Official entity type | Sole Proprietor |
No. of officers | 1 |
Contact
Address:
22 SIN MING LANE, #06-76, MIDVIEW CITY, Singapore 573969
Access Key Decision Makers
This is the legal entity page of PRESTIGE PR. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- View MorePrestige Biopharma (PBP) is an innovative biopharmaceutical company specializing in the discovery and development of innovative biologics and biosimilars. PBP1510 (Ulenistamab) is the First-in-Class Pancreatic Cancer drug which is on the stage of 1/2a global clinical phase. Based on our innovative biomarker, PAUF, we are continuing the challenge for overcoming hard-to-treat diseases such as pancreatic cancer. We are developing biosimilars to contribute on the patient's drug accessibility. Over 18 biosimilars we have been developing since 2015. And also, we are expanding the application of PAUF biomarker to the diagnostics. To expand the effectiveness of pancreatic cancer treatment, we are developing the diagnostic device. The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis. In parallel with our efforts to enhance safety, efficacy, and affordability of existing antibody therapeutics, PBP thrives to search for new targets and candidates with a goal to free mankind from devastating diseases Established on core values cherishing life and fostering the spirit of philanthropy, Prestige BioPharma promises to grow everyday to make our dream come true.
This is the legal entity page of PRESTIGE PR. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Revenue | < 1m |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of PRESTIGE PR?
- Where is PRESTIGE PR's headquarter?
- What is PRESTIGE PR's contact number?
- What PRESTIGE PR's spending power?
- Does PRESTIGE PR have a presence in the domain it operates in?